“Stories from the history of cardiac surgery and anesthesia — the people, the breakthroughs, and the hard-won lessons that shaped how we care for hearts today.”
Episode02

Blood Transfusion

April 2026

Blood product use in cardiac surgery — the full arc of transfusion, from ancient ideas about blood to modern blood management in the cardiac OR.

Apple Podcasts ↗
Show notes, articles & references

Show notes

  • Opens with Surgeon General Leonard D. Heaton's reflection from the 1964 Blood Program in World War II — transfusion as miraculous, yet lethal without precision.
  • Ancient roots: blood in Egyptian medicine (Ebers Papyrus, ~1550 BCE) and the humoral tradition of Hippocrates and Galen.
  • The Renaissance turn: Vesalius (De humani corporis fabrica, 1543), Harvey's circulation (1628), and Richard Lower's first animal-to-animal transfusion (Oxford, 1665).
  • First human transfusions: James Blundell's 1818 success for postpartum hemorrhage (Medical and Physical Journal); George Crile's first direct human-to-human transfusion (1905).
  • The three pillars of safe transfusion: Landsteiner's ABO groups (1901), sodium-citrate anticoagulation (Hustin 1914, Agote, Lewisohn), and Rous–Turner dextrose storage.
  • War as accelerator: Oswald Robertson's WWI blood depot (France, 1917), Cohn plasma fractionation (1946), and WWII's 'Blood for Britain' — with Charles Drew, who resigned over segregated-blood policy.
  • Into cardiac surgery: from liberal whole blood in the early bypass era to component therapy, cell salvage, antifibrinolytics (TXA, aminocaproic acid, aprotinin), and point-of-care testing (TEG, ROTEM).
  • The evidence and the ethos: restrictive-transfusion trials (TRICC, TRACS, TITRe2, FOCUS, CRASH-2), the STS/SCA blood-conservation guidelines, and patient blood management today.

Articles & resources

References

  • Kendrick DB. Blood Program in World War II. Washington, DC: Office of the Surgeon General, U.S. Army; 1964.
  • Giangrande PLF. The history of blood transfusion. Br J Haematol. 2000;110(4):758–767.
  • Landsteiner K. Über Agglutinationserscheinungen normalen menschlichen Blutes. Wien Klin Wochenschr. 1901;14:1132–1134.
  • Hébert PC, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care (TRICC). N Engl J Med. 1999;340(6):409–417.
  • Ferraris VA, et al. 2011 Update to the STS and SCA Blood Conservation Clinical Practice Guidelines. Ann Thorac Surg. 2011;91(3):944–982.
Episode01

Norman Shumway and the Birth of Heart Transplantation

April 2026

A look into the life and career of Dr. Norman Shumway — the man often called the Father of heart transplantation — and the race, the backlash, and the revival that followed.

Apple Podcasts ↗
Show notes, articles & references

Show notes

  • Frames the 'race' to the first human heart transplant — Christiaan Barnard, Norman Shumway, Richard Lower, and Adrian Kantrowitz — as chronicled in Donald McRae's Every Second Counts.
  • Shumway's roots: born in Kalamazoo, Michigan (1923); routed into medicine through the Army Specialized Training Program; medical school at Vanderbilt (1945).
  • Surgical training at the University of Minnesota under Wangensteen, Walt Lillehei, and John Lewis — assisting Lillehei's first cross-circulation, with PhD work in hypothermia.
  • At Stanford with Richard Lower, developed topical cardiac hypothermia and a reproducible canine heart-transplant technique ('Special Problems in Transplantation of the Heart,' Surgery, 1965).
  • Experimental lineage: Carrel & Guthrie's 1905 heterotopic transplant and Mann's 1933 work defining rejection.
  • The clinical race: Barnard's first human transplant (Cape Town, Dec 3, 1967) using the Lower–Shumway technique; Shumway's first U.S. adult transplant (Stanford, Jan 1968) — Mike Kasperak, who survived about two weeks.
  • The backlash: brain-death disputes and the Andrew Lyons trial, California's 1976 brain-death law, the 1970 moratorium Stanford defied, and Life magazine's 1971 'era of medical failure.'
  • The revival and the future: endomyocardial biopsy, the cyclosporine revolution (1-year survival from ~20% to >80%), modern immunosuppression and mechanical support, and where transplant is heading — DCD, ex-vivo perfusion, and xenotransplantation.

Articles & resources

References

  • Baumgartner WA, Reitz BA, Gott VL, Shumway SJ. Norman E. Shumway, MD, PhD: Visionary, innovator, humorist. J Thorac Cardiovasc Surg. 2009;137(2):269–277.
  • Lower RR, Shumway NE. Studies on orthotopic homotransplantation of the canine heart. Surg Forum. 1960;11:18–19.
  • Barnard CN. The operation. A human cardiac transplant... S Afr Med J. 1967;41(48):1271–1274.
  • McRae D. Every Second Counts: The Race to Transplant the First Human Heart. New York: G.P. Putnam's Sons; 2006.